A novel recombinant avian leukosis virus isolated from gamecocks induced pathogenicity in Three-Yellow chickens: a potential infection source of avian leukosis virus to the commercial chickens

Peikun Wang,Mengya Shi,Chengwei He,Lulu Lin,Haijuan Li,Zhanming Gu,Min Li,Yanli Gao,Teng Huang,Meilan Mo,Tianchao Wei,Ping Wei
DOI: https://doi.org/10.3382/ps/pez548
IF: 4.014
2019-12-01
Poultry Science
Abstract:One natural recombinant avian leukosis virus (<strong>ALV</strong>) strain GX14DJ3–18 was isolated from a native gamecock by DF-1 cell culture and identified with Polymerase Chain Reaction (<strong>PCR</strong>), immunofluorescence assay and the viral genome's nucleotide sequencing. This strain was revealed as a novel recombinant virus with nucleotide sequence similarities of 95.4% Long Terminal Repeated (<strong>LTR</strong>), 95.8% 5′, UTR, 97.9% <em>gag</em>, and 92.9% 3′untranslated regions (UTR) in ALV-J. Also we found sequence similarities of 99.3% <em>pol</em> and 99.0% gp37 in ALV-E, and 89.9% gp85 in ALV-A. The simulated congenital infection with GX14DJ3–18 in Three-Yellow chickens exhibited a significant negative effect on the development of immune organs (<em>P</em> &lt; 0.05). Also, lower antibody responses were found to vaccinations with the commercial vaccines of Newcastle disease virus and with subtypes H5 and H9 of avian influenza virus (<em>P</em> &lt; 0.05). The incidence of tumor or tumor-like lesions in the challenged birds was 14.28% (5/35), while none were observed in the un-challenged control group (0/35). These results suggested that GX14DJ3–18 is a novel recombinant ALV that can induce pathogenicity in the commercial Three-Yellow chickens. We speculated that cross-provincial sales of gamecocks in which ALVs have not been eradicated thoroughly might be a potential route for the transmission of ALVs to commercial chickens.
agriculture, dairy & animal science
What problem does this paper attempt to address?